Literature DB >> 21365451

Acute progressive mitral regurgitation resulting from chordal rupture in infants.

Hiroko Asakai1, Yukihiro Kaneko, Masahide Kaneko, Yasushi Misaki, Ikuya Achiwa, Yasutaka Hirata, Hitoshi Kato.   

Abstract

This report describes six previously healthy infants with acute mitral valve chordal rupture. Although their initial symptoms were mild respiratory distress and fever, all the infants presented with acute progressive left heart failure and required urgent surgical repair. Mitral valve annuloplasty and mitral valve replacement were performed (for three patients each). Two patients died, both of whom had cardiac arrest and required resuscitation before surgery. Histologic examination of excised mitral valve leaflets showed infiltration of gram-positive bacteria in these two patients. All the patients were 4-6 months old, which may suggest underlying congenital factors. The authors believe early diagnosis and surgery are crucial as a life-saving measure for infants with acute mitral valve chordal rupture.

Entities:  

Mesh:

Year:  2011        PMID: 21365451     DOI: 10.1007/s00246-011-9939-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  13 in total

1.  Rupture of mitral chorda tendinea following blunt chest trauma.

Authors:  A R Grinberg; J D Finkielman; D Piñeiro; H Festa; C Cazenave
Journal:  Clin Cardiol       Date:  1998-04       Impact factor: 2.882

2.  Acute mitral regurgitation due to chordal rupture in a patient with neonatal Marfan syndrome caused by a deletion in exon 29 of the FBN1 gene.

Authors:  M Weidenbach; R Brenner; T Rantamäki; D A Redel
Journal:  Pediatr Cardiol       Date:  1999 Sep-Oct       Impact factor: 1.655

3.  Treatment of ruptured or elongated anterior mitral valve chordae by partial transposition of the posterior leaflet: experience with 29 patients.

Authors:  A Lessana; M Romano; G Lutfalla; C Carbone; E Palsky; S A Amalou; M Escorsin
Journal:  Ann Thorac Surg       Date:  1988-04       Impact factor: 4.330

4.  Neonatal mitral and tricuspid valve repair for in utero papillary muscle rupture.

Authors:  Petros V Anagnostopoulos; Nelson Alphonso; Lars Nölke; Lisa K Hornberger; Gary W Raff; Anthony Azakie; Tom R Karl
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

5.  Midterm results of mitral valve repair with artificial chordae in children.

Authors:  Kazu Minami; Hideaki Kado; Sadahiro Sai; Hideki Tatewaki; Yuichi Shiokawa; Atsuhiro Nakashima; Koji Fukae; Hitoshi Hirose
Journal:  J Thorac Cardiovasc Surg       Date:  2005-02       Impact factor: 5.209

6.  Rupture of mitral chordae tendineae: adding to the list of hypertension complications.

Authors:  J J-M Juang; S-R Ke; J-L Lin; J-J Hwang; K-L Hsu; F-T Chiang; C-D Tseng; Y-Z Tseng; J-J Chen; F-C Hu; Y-T Lin; L-P Lai
Journal:  Heart       Date:  2009-02-15       Impact factor: 5.994

7.  Mitral valve chordal rupture masquerades as endocarditis.

Authors:  C W Baird; C Constantinos; E Lansford; F A Pigula
Journal:  Pediatr Cardiol       Date:  2007-06-11       Impact factor: 1.655

8.  Experiences with the Carpentier techniques of mitral valve reconstruction in 103 patients (1980-1985).

Authors:  F C Spencer; S B Colvin; A T Culliford; O W Isom
Journal:  J Thorac Cardiovasc Surg       Date:  1985-09       Impact factor: 5.209

9.  Severe mitral regurgitation due to cardiac amyloidosis--a rare reason for ruptured chordae.

Authors:  Hiroyuki Nishi; Masataka Mitsuno; Masaaki Ryomoto; Yuji Miyamoto
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-08-28

10.  Rupture of tendinous chords during acute rheumatic carditis in young children.

Authors:  M M de Moor; P I Lachman; D G Human
Journal:  Int J Cardiol       Date:  1986-09       Impact factor: 4.164

View more
  1 in total

Review 1.  Clinical Impact of Computational Heart Valve Models.

Authors:  Milan Toma; Shelly Singh-Gryzbon; Elisabeth Frankini; Zhenglun Alan Wei; Ajit P Yoganathan
Journal:  Materials (Basel)       Date:  2022-05-05       Impact factor: 3.748

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.